- Home
- OBE vs ZBIO Comparison
OBE vs ZBIO Comparison
Compare OBE & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBE
- ZBIO
- Stock Information
- Founded
- OBE 1979
- ZBIO 2019
- Country
- OBE Canada
- ZBIO United States
- Employees
- OBE N/A
- ZBIO N/A
- Industry
- OBE Oil & Gas Production
- ZBIO
- Sector
- OBE Energy
- ZBIO
- Exchange
- OBE Nasdaq
- ZBIO NYSE
- Market Cap
- OBE 372.4M
- ZBIO 339.3M
- IPO Year
- OBE N/A
- ZBIO 2024
- Fundamental
- Price
- OBE $5.64
- ZBIO $8.40
- Analyst Decision
- OBE Strong Buy
- ZBIO Strong Buy
- Analyst Count
- OBE 1
- ZBIO 5
- Target Price
- OBE $14.00
- ZBIO $31.75
- AVG Volume (30 Days)
- OBE 345.8K
- ZBIO 371.9K
- Earning Date
- OBE 02-25-2025
- ZBIO 02-16-2025
- Dividend Yield
- OBE N/A
- ZBIO N/A
- EPS Growth
- OBE N/A
- ZBIO N/A
- EPS
- OBE 1.05
- ZBIO N/A
- Revenue
- OBE $516,155,298.00
- ZBIO N/A
- Revenue This Year
- OBE $23.45
- ZBIO N/A
- Revenue Next Year
- OBE $5.39
- ZBIO N/A
- P/E Ratio
- OBE $5.37
- ZBIO N/A
- Revenue Growth
- OBE 3.06
- ZBIO N/A
- 52 Week Low
- OBE $4.87
- ZBIO $7.50
- 52 Week High
- OBE $9.07
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- OBE 48.24
- ZBIO N/A
- Support Level
- OBE $5.84
- ZBIO N/A
- Resistance Level
- OBE $6.26
- ZBIO N/A
- Average True Range (ATR)
- OBE 0.22
- ZBIO 0.00
- MACD
- OBE -0.01
- ZBIO 0.00
- Stochastic Oscillator
- OBE 25.30
- ZBIO 0.00
About OBE Obsidian Energy Ltd.
Obsidian Energy Ltd is an intermediate-sized oil and gas producer with strategic assets in Alberta. It operates in a single reporting segment that is exploration, development, and holding an interest in oil and natural gas properties and related production infrastructure in the Western Canada Sedimentary Basin. The company generates the majority of the revenue from the Crude oil sale.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.